The EGFR gene (Epidermal Growth Factor Receptor) plays a central role in the progression from Barrett’s esophagus to esophageal adenocarcinoma and has become a focus of increasing interest in molecular studies due to its clinical relevance. The gene discussed is EGFR; the disease is esophageal adenocarcinoma.